|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
CN100444830C
(zh)
|
1998-11-02 |
2008-12-24 |
伊兰公司，Plc |
多颗粒改进释放组合物
|
|
DK1140012T3
(da)
*
|
1998-12-17 |
2004-07-12 |
Alza Corp |
Omdannelse af væskefyldte gelatinekapsler til systemer til kontrolleret frigivelsessystemer ved flere coatinger
|
|
KR100738276B1
(ko)
*
|
1999-12-09 |
2007-07-12 |
알자 코포레이션 |
항바이러스성 약제
|
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
|
RU2325152C2
(ru)
*
|
2001-07-04 |
2008-05-27 |
Сан Фармасьютикл Индастриз Лимитид |
Удерживаемая в желудке система регулируемой доставки лекарственного средства
|
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
|
HUP0402451A3
(en)
*
|
2001-12-19 |
2008-04-28 |
Alza Corp |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
EP1458353A1
(en)
*
|
2001-12-19 |
2004-09-22 |
ALZA Corporation |
Formulation dosage form for the controlled delivery of ther apeutic agents
|
|
ATE376854T1
(de)
*
|
2002-06-26 |
2007-11-15 |
Alza Corp |
Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
|
|
AR040301A1
(es)
*
|
2002-06-28 |
2005-03-23 |
Alza Corp |
Composicion osmotica expansible y suspension para revestimiento mejoradas
|
|
KR20050071376A
(ko)
*
|
2002-06-28 |
2005-07-07 |
알자 코포레이션 |
액체 활성성분 제제를 포함하고 팽창성 삼투 조성물에의해 그의 방출을 제어하는 경구제형
|
|
RU2321391C2
(ru)
*
|
2002-07-29 |
2008-04-10 |
Алза Корпорейшн |
Способы и лекарственные формы для контролируемой доставки палиперидона
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
USD475451S1
(en)
|
2002-09-09 |
2003-06-03 |
Access Business Group International Llc |
Vitamin tablet
|
|
BR0315454A
(pt)
*
|
2002-10-21 |
2005-08-23 |
Givaudan Sa |
Composições pesticidas
|
|
EP1556000A1
(en)
*
|
2002-10-31 |
2005-07-27 |
Alza Corporation |
Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
|
|
US20040091538A1
(en)
*
|
2002-10-31 |
2004-05-13 |
Crystal Pollock-Dove |
Dosage form providing ascending release of liquid formulation
|
|
US7988993B2
(en)
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040131672A1
(en)
*
|
2003-01-07 |
2004-07-08 |
Nilobon Podhipleux |
Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
SI1635787T1
(sl)
*
|
2003-06-26 |
2012-04-30 |
Psivida Inc |
Bioeredibilni sistemi za oddajanje zdravil z zadrževanim sproščanjem
|
|
EP1635875B8
(en)
|
2003-06-26 |
2008-12-24 |
pSivida Inc |
In-situ gelling drug delivery system
|
|
WO2005000268A2
(en)
|
2003-06-26 |
2005-01-06 |
Control Delivery Systems, Inc. |
Bioerodible sustained release drug delivery systems
|
|
US20050003070A1
(en)
*
|
2003-07-03 |
2005-01-06 |
Foster David V. |
Shelf stable vitamin C in oatmeal products
|
|
EA015349B1
(ru)
*
|
2003-07-11 |
2011-06-30 |
Ф. Хоффманн-Ля Рош Аг |
Твёрдая разовая пероральная фармацевтическая дозированная форма саквинавирмезилата и способ её изготовления
|
|
CN1826100B
(zh)
*
|
2003-07-17 |
2010-12-22 |
旗帜药物胶囊公司 |
控释制剂
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
JP2007500558A
(ja)
*
|
2003-07-31 |
2007-01-18 |
アルザ・コーポレーシヨン |
液状活性製剤の制御型放出のための透過抵抗性浸透エンジンおよび投薬剤形物
|
|
EP1575565B1
(en)
*
|
2003-08-08 |
2010-01-06 |
Biovail Laboratories International Srl |
Modified-release tablet of bupropion hydrochloride
|
|
USD520635S1
(en)
|
2003-09-16 |
2006-05-09 |
Novartis Ag |
Combine capsule and tablets
|
|
USD530814S1
(en)
|
2003-09-16 |
2006-10-24 |
Novartis Ag |
Combined capsule and tablets
|
|
BRPI0414802A
(pt)
*
|
2003-09-26 |
2006-11-14 |
Alza Corp |
formas de dosagem osmóticas para liberação controlada de alprazolam
|
|
EP1689367A1
(en)
*
|
2003-10-21 |
2006-08-16 |
Actavis Group HF |
Pharmaceutical formulations containing quetiapine
|
|
WO2005048981A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Alza Corporation |
Controlled release of topirimate in liquid dosage forms
|
|
US20050181049A1
(en)
*
|
2003-11-19 |
2005-08-18 |
Dong Liang C. |
Composition and method for enhancing bioavailability
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
EP1593376A1
(en)
*
|
2004-05-04 |
2005-11-09 |
Warner-Lambert Company LLC |
Improved pullulan capsules
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
RU2404750C2
(ru)
|
2004-11-23 |
2010-11-27 |
Адамас Фармасьютикалс, Инк. |
Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту
|
|
CA2588296A1
(en)
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
|
WO2006063078A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Elan Corporation, Plc |
Topiramate pharmaceuticals composition
|
|
EP1827377B1
(en)
*
|
2004-12-14 |
2008-03-19 |
Novartis AG |
In-situ forming implant for animals
|
|
EP1858492B1
(en)
*
|
2005-01-27 |
2008-11-12 |
ALZA Corporation |
Oral osmotic dosage form having a high flux membrane
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
MX2007012374A
(es)
*
|
2005-04-06 |
2008-02-22 |
Adamas Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
|
|
CN101232868A
(zh)
*
|
2005-04-19 |
2008-07-30 |
阿尔扎公司 |
曲马多和加巴喷丁的控释递药剂型
|
|
WO2007037790A2
(en)
*
|
2005-06-08 |
2007-04-05 |
Elan Corporation, Plc |
Modified release famciclovir compositions
|
|
AR055099A1
(es)
*
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
|
US20070082046A1
(en)
*
|
2005-10-11 |
2007-04-12 |
Banner Pharmacaps, Inc. |
Enteric valproic acid
|
|
CA2624897C
(en)
*
|
2005-10-12 |
2017-02-14 |
Proventiv Therapeutics, Llc |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
EP1948183B1
(en)
*
|
2005-10-13 |
2013-12-18 |
Duke University |
Compositions for the treatment and prevention of heart disease and methods of using same
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
PT3095447T
(pt)
*
|
2006-02-03 |
2022-01-24 |
Opko Renal Llc |
Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
|
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
|
JP5143131B2
(ja)
|
2006-05-30 |
2013-02-13 |
インターシア セラピューティクス，インコーポレイティド |
浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
|
|
US20070281008A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Lin Shun Y |
Personal lubricant compositions and kits for providing personal lubrication
|
|
SI2037936T1
(sl)
|
2006-06-21 |
2014-11-28 |
Opko Renal, Llc |
Postopek zdravljenja in prepreäśevanja sekundarnega hiperparatiroidizma
|
|
DE102006032426A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
DE102006032427A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
US20080038334A1
(en)
*
|
2006-08-08 |
2008-02-14 |
John Zazula |
Method for producing and a system for cooling a hot-filled softgel capsule
|
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
EP2106732B1
(en)
*
|
2007-01-30 |
2016-03-16 |
Olympus Corporation |
Device for checking for lumen passage and method of producing device for checking for lumen passage
|
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
|
CN101715340A
(zh)
|
2007-04-23 |
2010-05-26 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
|
EP2148684B1
(en)
|
2007-04-25 |
2013-01-16 |
Cytochroma Inc. |
Method of treating vitamin d insufficiency and deficiency
|
|
SI2481400T1
(sl)
|
2007-04-25 |
2014-11-28 |
Opko IP Holdings II, Inc. |
Nadzorovano oralno sproščanje sestavkov, ki vsebujejo spojino vitamina D in voskasti nosilec
|
|
EP3225243B1
(en)
|
2007-04-25 |
2025-09-03 |
Opko Renal, LLC |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
|
JP5647516B2
(ja)
|
2007-04-25 |
2014-12-24 |
シトクロマ インコーポレイテッド |
ビタミンｄ療法のための方法および化合物
|
|
DK2155169T3
(en)
*
|
2007-06-08 |
2016-06-13 |
Boehringer Ingelheim Int |
Formulation of nevirapine extended release
|
|
EP2187873B1
(en)
*
|
2007-08-13 |
2018-07-25 |
Abuse Deterrent Pharmaceutical Llc |
Abuse resistant drugs, method of use and method of making
|
|
WO2009050190A2
(en)
*
|
2007-10-15 |
2009-04-23 |
Glaxo Group Limited |
Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms
|
|
CN101827572A
(zh)
*
|
2007-10-15 |
2010-09-08 |
葛兰素集团有限公司 |
用于释放药物组合物的有板条的胶囊壳
|
|
US8293159B2
(en)
*
|
2007-10-15 |
2012-10-23 |
Capsugel Belgium |
Method and apparatus for manufacturing filled linkers
|
|
US20090110724A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of pain
|
|
AU2008324787B2
(en)
*
|
2007-11-05 |
2013-10-10 |
Ala Wai Pharma, Inc. |
Formulations for enhanced bioavailability of orally administered polar agents
|
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
|
CA2711014C
(en)
|
2007-12-28 |
2018-10-23 |
Impax Laboratories, Inc. |
Controlled release formulations of levodopa and uses thereof
|
|
US8343140B2
(en)
|
2008-02-13 |
2013-01-01 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
ES2593356T3
(es)
|
2008-04-02 |
2016-12-07 |
Opko Ireland Global Holdings, Ltd. |
Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
CN105581984A
(zh)
*
|
2009-04-09 |
2016-05-18 |
阿尔科米斯制药爱尔兰有限公司 |
药物递送组合物
|
|
SMT202000093T1
(it)
|
2009-06-16 |
2020-03-13 |
Pfizer |
Forme di dosaggio di apixaban
|
|
WO2011006066A1
(en)
|
2009-07-10 |
2011-01-13 |
Ironwood Pharmaceuticals, Inc. |
Cb receptor agonists
|
|
CN101596174B
(zh)
*
|
2009-07-13 |
2011-04-06 |
北京航洋胶囊技术有限公司 |
一种软胶囊及其制备方法
|
|
KR102093612B1
(ko)
|
2009-09-28 |
2020-03-26 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
|
RU2012117898A
(ru)
|
2009-09-30 |
2013-11-10 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Кофакторы и способы их применения индивидуумами
|
|
AU2010308021A1
(en)
|
2009-10-16 |
2012-05-17 |
Ranbaxy Laboratories Limited |
Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
|
|
JP5885668B2
(ja)
|
2009-12-02 |
2016-03-15 |
アダマス ファーマシューティカルズ， インコーポレイテッド |
アマンタジン組成物および使用方法
|
|
EA201200855A1
(ru)
|
2009-12-23 |
2013-04-30 |
Айронвуд Фармасьютикелз, Инк. |
Модуляторы crth2
|
|
WO2011100324A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals Inc. |
Cannabinoid receptor agonists
|
|
WO2011100359A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid agonists
|
|
WO2011115804A1
(en)
|
2010-03-17 |
2011-09-22 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
US8486013B2
(en)
*
|
2010-03-18 |
2013-07-16 |
Biotronik Ag |
Balloon catheter having coating
|
|
LT2552484T
(lt)
|
2010-03-29 |
2020-04-27 |
Opko Ireland Global Holdings, Ltd. |
Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
|
|
JP5894574B2
(ja)
*
|
2010-04-22 |
2016-03-30 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
WO2011161666A2
(en)
*
|
2010-06-21 |
2011-12-29 |
White Innovation Ltd. |
Enclosed liquid capsules
|
|
EP3173407A1
(en)
|
2010-06-30 |
2017-05-31 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
WO2012009134A1
(en)
|
2010-07-12 |
2012-01-19 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
RU2016101964A
(ru)
|
2010-11-09 |
2018-11-21 |
Айронвуд Фармасьютикалз, Инк. |
СТИМУЛЯТОРЫ sGC
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
CA2841748C
(en)
|
2011-07-15 |
2021-06-15 |
Nusirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
|
TWI615155B
(zh)
*
|
2011-11-01 |
2018-02-21 |
拜耳股份有限公司 |
滲透活性的陰道遞送系統
|
|
US9139564B2
(en)
|
2011-12-27 |
2015-09-22 |
Ironwood Pharmaceuticals, Inc. |
2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
|
|
CN103211797B
(zh)
*
|
2012-01-18 |
2017-06-06 |
北京天衡医院管理有限公司 |
盐酸维拉帕米膜控缓释微丸胶囊
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
US20150080381A1
(en)
|
2012-04-12 |
2015-03-19 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
|
WO2013155505A1
(en)
|
2012-04-14 |
2013-10-17 |
Intra-Cellular Therapies, Inc |
Organic compounds
|
|
WO2013165789A1
(en)
*
|
2012-04-30 |
2013-11-07 |
Dow Agrosciences Llc |
Pesticide composition delivery vehicles
|
|
JP6227646B2
(ja)
*
|
2012-07-23 |
2017-11-08 |
ロッテ精密化學株式会社ＬＯＴＴＥ Ｆｉｎｅ Ｃｈｅｍｉｃａｌ Ｃｏ．，Ｌｔｄ． |
硬質カプセル製造用水性組成物及びその製造方法、硬質カプセル、並びに硬質カプセルスクラップの再活用方法
|
|
WO2014047111A1
(en)
|
2012-09-18 |
2014-03-27 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
EP2897953B8
(en)
|
2012-09-19 |
2019-06-26 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
|
EP2919772B1
(en)
|
2012-11-13 |
2019-03-27 |
NuSirt Sciences, Inc. |
Pde5 inhibitors and leucine or a leucine metabolite for use in the treatment of diabetes
|
|
EP2945616B1
(en)
|
2013-01-15 |
2018-11-28 |
NuSirt Sciences, Inc. |
Treating pulmonary conditions
|
|
GB201303781D0
(en)
|
2013-03-04 |
2013-04-17 |
Gauthier Pierre Pascal |
Oral timer device and method of using same
|
|
US20140275150A1
(en)
|
2013-03-15 |
2014-09-18 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
|
KR20150130455A
(ko)
|
2013-03-15 |
2015-11-23 |
뉴서트 사이언시스, 인크. |
지질 수준을 감소시키는 류신 및 니코틴산
|
|
US9708322B2
(en)
|
2013-03-15 |
2017-07-18 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
|
|
BR112015023349A2
(pt)
|
2013-03-15 |
2017-07-18 |
Ironwood Pharmaceuticals Inc |
composto, composição farmacêutica, e, método de tratamento de uma doença, condição de saúde ou distúrbio
|
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 ｄ 방출 제형
|
|
CN103315973B
(zh)
*
|
2013-05-24 |
2014-05-07 |
杭州和正医药有限公司 |
喹硫平的渗透泵型控释制剂
|
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
|
EP2839853A1
(de)
*
|
2013-08-23 |
2015-02-25 |
LTS LOHMANN Therapie-Systeme AG |
Transdermales therapeutisches System mit Druckerzeugungsvorrichtung
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
CA2926082C
(en)
*
|
2013-10-07 |
2022-06-14 |
Impax Laboratories, Inc. |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
KR102373288B1
(ko)
|
2013-12-03 |
2022-03-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
MX2016007522A
(es)
|
2013-12-11 |
2017-12-15 |
Ironwood Pharmaceuticals Inc |
Estimuladores de guanilato ciclasa soluble (sgc).
|
|
KR102161001B1
(ko)
*
|
2013-12-31 |
2020-09-29 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
KR102199596B1
(ko)
*
|
2013-12-31 |
2021-01-07 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
AU2015222754B2
(en)
|
2014-02-27 |
2020-06-25 |
Nusirt Sciences Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
JP2017509686A
(ja)
|
2014-04-04 |
2017-04-06 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
AU2015240526A1
(en)
|
2014-04-04 |
2016-11-24 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2015191554A1
(en)
|
2014-06-09 |
2015-12-17 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
US10220047B2
(en)
|
2014-08-07 |
2019-03-05 |
Opko Ireland Global Holdings, Ltd. |
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
|
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
|
WO2016044447A1
(en)
|
2014-09-17 |
2016-03-24 |
Ironwood Pharmaceuticals, Inc. |
Pyrazole derivatives as sgc stimulators
|
|
US20170298055A1
(en)
|
2014-09-17 |
2017-10-19 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
JP2017527604A
(ja)
|
2014-09-17 |
2017-09-21 |
アイアンウッド ファーマシューティカルズ インコーポレイテッド |
ｓＧＣ刺激剤
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US9808608B2
(en)
*
|
2014-11-16 |
2017-11-07 |
International Business Machines Corporation |
Helical coil delivery device for active agent
|
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
US20170119680A1
(en)
|
2015-10-30 |
2017-05-04 |
R.P. Scherer Technologies, Llc |
Extended release film-coated capsules
|
|
AU2016381366A1
(en)
|
2015-12-30 |
2018-06-28 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
MX385678B
(es)
|
2016-01-26 |
2025-03-18 |
Intra Cellular Therapies Inc |
Gamma-carbolinas heterocíclicas fusionadas sustituidas, composiciones farmacéuticas y métodos de uso.
|
|
IL297676B2
(en)
|
2016-03-25 |
2023-12-01 |
Intra Cellular Therapies Inc |
A controlled or delayed release pharmaceutical preparation containing a deuterated compound
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
MY198547A
(en)
|
2016-03-28 |
2023-09-04 |
Opko Ireland Global Holdings Ltd |
Methods of vitamin d treatment
|
|
RU2760007C2
(ru)
|
2016-05-16 |
2021-11-22 |
Интарсия Терапьютикс, Инк. |
Полипептиды, селективные к рецепторам глюкагона, и способы их применения
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
CA3028450A1
(en)
*
|
2016-07-06 |
2018-01-11 |
Durect Corporation |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
IL292968B2
(en)
|
2016-09-02 |
2025-10-01 |
Cyclerion Therapeutics Inc |
SCG racers merge on bicycles
|
|
EP3525763B1
(en)
|
2016-10-12 |
2025-03-05 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
KR102475124B1
(ko)
|
2016-11-08 |
2022-12-08 |
사이클리온 테라퓨틱스, 인크. |
sGC 자극제를 사용한 CNS 질환의 치료
|
|
CA3042713A1
(en)
|
2016-11-08 |
2018-05-17 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
|
US10906906B2
(en)
|
2016-12-29 |
2021-02-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CA3049034A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
|
IL304026B2
(en)
|
2017-03-24 |
2024-11-01 |
Intra Cellular Therapies Inc |
A pharmaceutical preparation containing 1-(4-fluoro-phenyl)-4-((Sa10,Rb6)-3-D2-2,2-methyl-2, 3, a10, 10, 9, b6- hexahydro-H7, H1- Pyrido[3',4',:4,5]pyrrolo[3,2,1-de]quioxalin-8-yl)-butan-1-one and its uses
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
JP7223742B2
(ja)
|
2017-07-26 |
2023-02-16 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
MX2020000967A
(es)
|
2017-07-26 |
2020-09-28 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
EP3765021A4
(en)
|
2018-03-16 |
2022-03-09 |
Intra-Cellular Therapies, Inc. |
NOVEL PROCESSES
|
|
BR112020019181A2
(pt)
|
2018-03-23 |
2021-01-05 |
Intra-Cellular Therapies, Inc. |
Compostos orgânicos
|
|
JP7462568B2
(ja)
|
2018-03-23 |
2024-04-05 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
WO2019204187A1
(en)
*
|
2018-04-15 |
2019-10-24 |
Optofluidic Bioassay, Llc |
Differential pressure assisted drainage system
|
|
EP3801527B1
(en)
|
2018-06-08 |
2025-02-19 |
Intra-Cellular Therapies, Inc. |
Fused gamma-carbolines for acute treatment of anxiety or depression
|
|
CA3240552A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
WO2020047241A1
(en)
|
2018-08-29 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
|
BR112021003655A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
|
CN118873536A
(zh)
|
2018-08-31 |
2024-11-01 |
细胞内治疗公司 |
新方法
|
|
WO2020131899A1
(en)
|
2018-12-17 |
2020-06-25 |
Intra-Cellular Therapies, Inc. |
Organic compound
|
|
BR112022000231A2
(pt)
|
2019-07-07 |
2022-02-22 |
Intra Cellular Therapies Inc |
Novos métodos
|
|
WO2021119334A1
(en)
|
2019-12-11 |
2021-06-17 |
Intra-Cellular Therapies, Inc. |
Organic compound
|
|
US10940088B1
(en)
*
|
2020-01-09 |
2021-03-09 |
King Saud University |
Method of preparing low dose pharmaceutical formulations
|
|
CN112641751B
(zh)
*
|
2020-09-25 |
2022-06-21 |
广州玖洲胶囊生物科技有限公司 |
一种羟丙甲基纤维素和卡拉胶的填充空心充液胶囊
|
|
US12194150B2
(en)
|
2020-12-22 |
2025-01-14 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|
|
KR20250123225A
(ko)
|
2022-12-30 |
2025-08-14 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
CN116650438A
(zh)
*
|
2023-06-26 |
2023-08-29 |
江苏理工学院 |
一种软胶囊囊壳、可实现快速移动的软胶囊及制备方法
|
|
WO2026011136A1
(en)
|
2024-07-03 |
2026-01-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2026011166A1
(en)
|
2024-07-03 |
2026-01-08 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycles for use in the treatment of diseases involving the 5-ht2a receptor
|